Showing results (71-80 of 214) with videos related to

Sort By:
Pageof 22
Mbio|March 28, 2023
Viral Gastroenteritis: Sickness Symptoms and Behavioral ResponsesArash Hellysaz, Magdalena Neijd, Timo Vesikari, et al.
Expert Review of Vaccines|October 25, 2023
PreHevbrio: the first approved 3-antigen hepatitis B vaccineTimo Vesikari, Joanne M Langley, Vlad Popovic, et al.
Human Vaccines & Immunotherapeutics|August 22, 2012
Assessment of squalene adjuvanted and non-adjuvanted vaccines against pandemic H1N1 influenza in children 6 months to 17 years of ageTimo Vesikari, Stéphanie Pepin, Inca Kusters, et al.
The Pediatric Infectious Disease Journal|July 26, 2016
Decrease of Rotavirus Gastroenteritis to a Low Level Without Resurgence for Five Years After Universal RotaTeq Vaccination in FinlandMaria Hemming-Harlo, Jukka Markkula, Leena Huhti, et al.
Vaccine|September 13, 2011
Trivalent and quadrivalent MF59(®)-adjuvanted influenza vaccine in young children: a dose- and schedule-finding studyGiovanni Della Cioppa, Timo Vesikari, Etienne Sokal, et al.
The Pediatric Infectious Disease Journal|May 6, 2010
Sustained efficacy of the pentavalent rotavirus vaccine, RV5, up to 3.1 years following the last dose of vaccineTimo Vesikari, Aino Karvonen, Shannon Allen Ferrante, et al.
Human Vaccines & Immunotherapeutics|July 11, 2012
Homologous and heterologous antibody responses to a one-year booster dose of an MF59(®) adjuvanted A/H5N1 pre-pandemic influenza vaccine in pediatric subjectsTimo Vesikari, Aino Forstén, Astrid Borkowski, et al.
Vaccine|March 30, 2011
Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life: An open, randomized controlled trialTimo Vesikari, Aino Karvonen, Veronique Bianco, et al.
European Journal of Pediatrics|January 31, 2013
Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in FinlandMaria Hemming, Sirpa Räsänen, Leena Huhti, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 16, 2019
Immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in children and adolescents: A phase III randomized studyTimo Vesikari, Jos Nauta, Giulia Lapini, et al.
Pageof 22